Aktis reports imaging data for cancer drug targeting B7-H3 protein

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. DFTX
9. NAVN
10. IBM

Go back to Aktis reports imaging data for cancer drug targeting B7-H3 protein
(NASDAQ: AKTS) Delayed: 24.79 --0 (-0%)
Previous Close $24.79    52 Week High $5.77 
Open $24.79    52 Week Low $1.51 
Day High $24.79    P/E N/A 
Day Low $24.79    EPS $0.00 
Volume 15